Skip to main content
Journal of Genetic Engineering and Biotechnology

Table 2 Distribution of CNV in HCC patients

From: The role of BCL9 genetic variation as a biomarker for hepatitis C-related hepatocellular carcinoma in Egyptian patients

CNV

All HCC patients, N = 50

Male patients, n = 39

Female patients, n = 11

P-value

Gain

7 (14%)

7 (17.95%)

0 (0%)

0.324

No gain

43 (86%)

32 (82.05%)

11 (100%)

  1. CNV copy number variation
Back to article page